Analysis of reactivation of cytomegalovirus in low grade B-cell lymphoma patients treated with bendamustine

Analysis of reactivation of cytomegalovirus in low grade B-cell lymphoma patients treated with bendamustine - Reactivation of cytomegalovirus in bendamustine-treated patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006929

Enrollment

Registered

2011-12-24

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low grade B-cell lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who gave written informed consent abotu this study

Exclusion criteria

Exclusion criteria: 1. primary immunodeficiency, AIDS 2. past history of reactivation of cytomegalovirus

Design outcomes

Primary

Measure	Time frame
Analysis of reactivation of cytomegalovirus in the treatment with bendamustine	—

Countries

Japan

Contacts

Public ContactYoichi Imai

Tokyo Women's Medical University Department of Hematology

imaiyo@dh.twmu.ac.jp03-3353-8111

Outcome results